You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 5, 2025

Details for Patent: 10,676,440


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,676,440 protect, and when does it expire?

Patent 10,676,440 protects AKYNZEO and is included in one NDA.

This patent has eight patent family members in eight countries.

Summary for Patent: 10,676,440
Title:Crystalline forms of an NK-1 antagonist
Abstract: The present invention is related to crystalline forms of 2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethyl-N-(6-(4-methylpiperazin-1- -yl)-4-(o-tolyl)pyridin-3-yl)propanamide which is an NK-1 antagonist useful in the treatment of induced vomiting and other disorders.
Inventor(s): Bacilieri; Christian (Breganzona, CH), Frasca; Gionata (Minusio, CH)
Assignee: Helsinn Healthcare SA (Lugano/Pazzallo, CH)
Application Number:16/259,913
Patent Claim Types:
see list of patent claims
Composition; Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,676,440: A Comprehensive Analysis

Introduction

When analyzing a patent, particularly one like United States Patent 10,676,440, it is crucial to delve into its scope, claims, and the broader patent landscape. This article will provide a detailed examination of these aspects, helping business professionals and inventors navigate the complexities of patent law.

What is a Patent?

A patent is a form of intellectual property that grants the patent holder the exclusive right to make, use, and sell an invention for a specified period, usually 20 years from the filing date of the patent application[2].

The Role of the USPTO

The United States Patent and Trademark Office (USPTO) is the agency responsible for granting U.S. patents and registering trademarks. The USPTO plays a critical role in evaluating patent applications to ensure that the inventions meet the criteria of novelty, non-obviousness, and utility[2].

Patent Scope and Claims

The scope of a patent is defined by its claims, which are the legal descriptions of the invention for which protection is sought. These claims must be clear, concise, and supported by the patent's specification. The Patent Claims Research Dataset by the USPTO provides detailed information on claims from U.S. patents, including claim-level statistics and document-level statistics, which can help in understanding the scope of patents[3].

Claim Types

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.
  • Method Claims: These claims describe a process or method.
  • Apparatus Claims: These claims describe a physical device or system.

Claim Construction

Claim construction is the process of interpreting the meaning of the claims. This is crucial in determining the scope of the patent and is often a point of contention in patent litigation.

Patent 10,676,440: An Overview

To analyze the scope and claims of United States Patent 10,676,440, one must start by reviewing the patent document itself. Here are some key points to consider:

Title and Abstract

The title and abstract provide a general overview of the invention. This helps in understanding the broad scope of what the patent covers.

Background of the Invention

This section provides context and explains the problem the invention solves. It can give insights into why the invention is novel and non-obvious.

Summary of the Invention

This section summarizes the key aspects of the invention, including its components and how it works.

Detailed Description of the Invention

This is the most critical part of the patent, as it provides a detailed description of the invention, including drawings and examples.

Claims

The claims section is where the legal boundaries of the invention are defined. Each claim must be carefully analyzed to understand what is protected.

Obviousness-Type Double Patenting (ODP)

ODP is a doctrine that prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to a grant of Patent Term Adjustment (PTA) or other extensions. This is relevant when analyzing patents that are part of a family, as seen in the case of In re Cellect LLC[1].

Patent Term Adjustment (PTA)

PTA is a mechanism to adjust the term of a patent to account for delays during the prosecution process. However, as illustrated in In re Cellect LLC, PTA can sometimes lead to ODP issues if not managed properly[1].

Patent Landscape

Understanding the patent landscape involves identifying related patents, both those owned by the same entity and those owned by competitors. This can be done using databases such as the Patent Claims Research Dataset provided by the USPTO[3].

Prior Art Search

Conducting a prior art search is essential to determine whether an invention is novel and non-obvious. This involves searching through existing patents, publications, and other sources to find similar inventions[4].

Competitor Analysis

Analyzing competitors' patents can help in identifying gaps in the market and potential areas for innovation. It also helps in avoiding infringement issues.

Legal and Policy Considerations

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court, which could simplify and reduce the costs associated with patent litigation. The Administrative Conference of the United States (ACUS) has conducted extensive research on this topic, engaging with various stakeholders and legal experts[5].

Terminal Disclaimers

Terminal disclaimers are often used to overcome ODP rejections. They involve disclaiming the term of a later patent to ensure it does not extend beyond the term of an earlier patent[1].

Practical Implications for Business Professionals

Patent Strategy

Business professionals need to develop a robust patent strategy that includes regular monitoring of the patent landscape, conducting thorough prior art searches, and carefully drafting claims to ensure broad protection.

Litigation Preparedness

Understanding the scope and claims of a patent is crucial for litigation preparedness. This involves being aware of potential ODP issues and having a strategy to address them.

Innovation and R&D

Patent analysis can drive innovation by identifying areas where existing patents do not cover, thus guiding R&D efforts.

Key Takeaways

  • Patent Scope: Defined by the claims, which must be clear and supported by the specification.
  • Claim Construction: Critical in determining the scope of the patent.
  • ODP: Prevents securing a second, later-expiring patent for the same invention.
  • PTA: Adjusts the patent term for prosecution delays but can lead to ODP issues.
  • Patent Landscape: Understanding related patents and prior art is essential for innovation and avoiding infringement.
  • Legal Considerations: Terminal disclaimers and potential small claims patent courts are important legal aspects to consider.

FAQs

What is the purpose of the USPTO?

The USPTO is responsible for granting U.S. patents and registering trademarks, ensuring that inventions meet the criteria of novelty, non-obviousness, and utility[2].

How do you determine the scope of a patent?

The scope of a patent is determined by its claims, which must be clear, concise, and supported by the patent's specification[3].

What is Obviousness-Type Double Patenting (ODP)?

ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to a grant of PTA or other extensions[1].

Why is a prior art search important?

A prior art search is crucial to determine whether an invention is novel and non-obvious, helping to avoid infringement issues and ensure the validity of the patent[4].

What is a terminal disclaimer in patent law?

A terminal disclaimer involves disclaiming the term of a later patent to ensure it does not extend beyond the term of an earlier patent, often used to overcome ODP rejections[1].

Sources

  1. In re Cellect, LLC, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. U.S. Patent and Trademark Office (USPTO), USAGov.
  3. Patent Claims Research Dataset, USPTO.
  4. How to Search for an Historical U.S. Patent, NYPL Libguides.
  5. U.S. Patent Small Claims Court, Administrative Conference of the United States.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,676,440

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Helsinn Hlthcare AKYNZEO netupitant; palonosetron hydrochloride CAPSULE;ORAL 205718-001 Oct 10, 2014 RX Yes Yes 10,676,440 ⤷  Try for Free Y Y ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 1 of 1 entries

International Family Members for US Patent 10,676,440

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2015323515 ⤷  Try for Free
Canada 2960599 ⤷  Try for Free
China 107001275 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.